{"id":143005,"date":"2023-02-28T08:36:16","date_gmt":"2023-02-28T13:36:16","guid":{"rendered":"https:\/\/44.250.171.167\/?p=143005"},"modified":"2023-04-25T08:25:16","modified_gmt":"2023-04-25T12:25:16","slug":"shilpa-medicare-limited-q3fy23-earnings","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/shilpa-medicare-limited-q3fy23-earnings\/","title":{"rendered":"Shilpa Medicare Limited Q3FY23 Earnings"},"content":{"rendered":"\n

With cutting-edge technology, Shilpa Medicare<\/a> is in the business of manufacturing high-quality Active Pharmaceutical Ingredients, Intermediates, Formulations, Novel Drug delivery system, Peptides, Biotechnology goods, and Specialty chemicals. SML is among the top providers of oncology- and non-oncology-related intermediates and APIs in the world.<\/p>\n\n\n\n

Financial Results – Management Commentary<\/h2>\n\n\n\n

“The company also undertook certain cost rationalization initiatives, which along with the improvement in our gross margin resulted in improving our EBITDA to INR34 crores, which is about 12.8% of our revenue from INR16.6 crores, which was 6.2% of our revenues during last quarter.<\/em><\/p>

Now talking about the nine month performance. So our overall revenues stood at INR802 crores as compared to INR814 crores during corresponding period last year and gross profit stood at about INR475 crores, which was a margin of about 59%. Our EBITDA for the nine months stood at INR79 crores on a consolidated basis, that\u2019s 9.9% on our top line.<\/em><\/p>

And I would also like to quickly take you through our capex that we have incurred during the quarter at the Group level since ours is a manufacturing focused company. So in Q3, we have invested about INR53 crores in capex in various divisions, but predominantly, about INR43 crores have been invested in our Albumin facility and about INR10 crores have been invested in our \u2014 as maintenance capex in our API and formulations plants.<\/em>“<\/p>– Alpesh Dalal<\/strong>, Chief Financial Officer<\/em> (In Q3FY23 Concall<\/a>)<\/cite><\/blockquote>\n","protected":false},"excerpt":{"rendered":"

With cutting-edge technology, Shilpa Medicare is in the business of manufacturing high-quality Active Pharmaceutical Ingredients, Intermediates, Formulations, Novel Drug delivery system, Peptides, Biotechnology goods, and Specialty chemicals. SML is among the top providers of oncology- and non-oncology-related intermediates and APIs in the world. Financial Results – Management Commentary “The company also undertook certain cost rationalization […]<\/p>\n","protected":false},"author":1885,"featured_media":138183,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392,5747,6352],"tags":[11776,10162],"class_list":["post-143005","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-earnings","category-healthcare-stocks","category-research-summary","tag-active-pharmaceutical-ingredients","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2022\/11\/tiny-pharmacist-with-pills-vitamins-flat-vector-illustration-doctors-writing-prescriptions-antibiotics-working-together-helping-patients-cure-pharmacy-business-drugstore-concept_74855-23225.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":157236,"url":"https:\/\/alphastreet.com\/india\/shilpa-medicare-ltd-q2fy24-19-rise-in-revenue\/","url_meta":{"origin":143005,"position":0},"title":"Shilpa Medicare Ltd Q2FY24; 19% rise in Revenue","author":"Chirag Gupta","date":"December 11, 2023","format":false,"excerpt":"Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system, Peptides, Biotech products, and Specialty chemicals using sophisticated technology. SML is one of the worlds leading suppliers of Oncology\/ Non Oncology API's and intermediates. Financial Results: Shilpa Medicare Ltd reported\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":159746,"url":"https:\/\/alphastreet.com\/india\/shilpa-medicare-ltd-q3fy24-9-rise-in-revenue\/","url_meta":{"origin":143005,"position":1},"title":"Shilpa Medicare Ltd Q3FY24; 9% rise in Revenue","author":"Chirag Gupta","date":"March 12, 2024","format":false,"excerpt":"Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system, Peptides, Biotech products, and Specialty chemicals using sophisticated technology. SML is one of the worlds leading suppliers of Oncology\/ Non Oncology API's and intermediates. Financial Results: Shilpa Medicare Ltd reported\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-116.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-116.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-116.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-116.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-116.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-116.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152407,"url":"https:\/\/alphastreet.com\/india\/shilpa-medicare-ltd-q1fy24-50-fall-in-profits\/","url_meta":{"origin":143005,"position":2},"title":"Shilpa Medicare Ltd Q1FY24; 50% fall in Profits","author":"Chirag Gupta","date":"August 10, 2023","format":false,"excerpt":"Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system, Peptides, Biotech products, and Specialty chemicals using sophisticated technology. SML is one of the worlds leading suppliers of Oncology\/ Non Oncology API's and intermediates. Financial Results: Shilpa Medicare Ltd reported\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-579.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-579.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-579.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-579.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-579.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-579.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":161548,"url":"https:\/\/alphastreet.com\/india\/shilpa-medicare-ltd-q4fy24-11-rise-in-revenue\/","url_meta":{"origin":143005,"position":3},"title":"Shilpa Medicare Ltd Q4FY24; 11% rise in Revenue","author":"Chirag Gupta","date":"May 23, 2024","format":false,"excerpt":"Shilpa Medicare Incorporated in 1987 manufactures niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service for some of its customers. The company\u2019s formulation products consist of 16 injectable dosage forms, 19 oral solid dosage forms under SML and 13 formulations under SML\u2019s wholly owned subsidiary Shilpa\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-178.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-178.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-178.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-178.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-178.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-178.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":164607,"url":"https:\/\/alphastreet.com\/india\/shilpa-medicare-ltd-q1fy24-50-fall-in-profits-2\/","url_meta":{"origin":143005,"position":4},"title":"Shilpa Medicare Ltd Q1FY24; 50% fall in Profits","author":"Chirag Gupta","date":"October 1, 2024","format":false,"excerpt":"Shilpa Medicare Incorporated in 1987 manufactures niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service for some of its customers. The company\u2019s formulation products consist of 16 injectable dosage forms, 19 oral solid dosage forms under SML and 13 formulations under SML\u2019s wholly owned subsidiary Shilpa\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-4.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-4.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-4.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-4.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-4.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-4.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166311,"url":"https:\/\/alphastreet.com\/india\/aarti-drugs-ltd-q2fy25-12-fall-in-profits\/","url_meta":{"origin":143005,"position":5},"title":"Aarti Drugs Ltd Q2FY25; 12% fall in Profits","author":"Divyansh_Kasana","date":"January 10, 2025","format":false,"excerpt":"Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into manufacturing and selling Active Pharmaceutical Ingredients (API's), Pharma Intermediates, Specialty Chemicals as well as Formulations. Financial Results: Aarti Drugs Ltd reported Revenues for Q2FY25 of \u20b9598.00 Crores down\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/O-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/O-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/O-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/O-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/O-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/O-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/143005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1885"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=143005"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/143005\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/138183"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=143005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=143005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=143005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}